Pediatric optic neuritis

Does a prolonged course of steroids reduce relapses? A preliminary study

Himali Jayakody, Daniel J. Bonthius, Reid Longmuir, Charuta Joshi

Research output: Contribution to journalArticle

Abstract

Background Optic neuritis is an important pediatric disorder causing visual impairment. Because of the absence of pediatric-specific studies, data extrapolated from the adult-based optic neuritis treatment trial are used to guide management of pediatric patients. Recent literature promotes a prolonged course of oral steroids to prevent relapses. However, there are no published data to support this view.

Patients who were recently treated in our hospital received a longer course of steroids, relative to those treated several years ago. We hypothesized that a longer course of steroids results in fewer relapses and better final visual acuity.

Methods A retrospective analysis of 26 consecutive patients (age 4.5-19 years) treated for optic neuritis within the past 10 years was conducted.

Patients received either a short course (2 weeks) or a prolonged course (more than 2 weeks) of steroids. Some patients were not treated. Mean follow-up was 70 weeks (3 weeks-10 years). Comparisons were made among the groups receiving 2 weeks of steroid treatment (16 of 26 patients) and greater than 2 weeks of steroid treatment (seven of 26 patients) to evaluate relapse rate, eventual visual acuity, and reported side effects.

Results There were no significant differences in the relapse rates, reported side effects, and final visual acuity in the two treatment groups.

Conclusions In this cohort, a prolonged course of steroids was not associated with reduced relapse rate, increased side effects, or improved visual outcome. This cohort was small, but the results do not identify any reason to deviate from the common approach of optic neuritis treatment, which is 2 weeks of steroids.

Original languageEnglish (US)
Pages (from-to)721-725
Number of pages5
JournalPediatric Neurology
Volume51
Issue number5
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Optic Neuritis
Steroids
Pediatrics
Recurrence
Visual Acuity
Therapeutics
Vision Disorders

Keywords

  • optic neuritis
  • pediatrics
  • steroid treatment
  • visual acuity
  • visual impairment
  • visual outcome

ASJC Scopus subject areas

  • Clinical Neurology
  • Pediatrics, Perinatology, and Child Health
  • Developmental Neuroscience
  • Neurology
  • Medicine(all)

Cite this

Pediatric optic neuritis : Does a prolonged course of steroids reduce relapses? A preliminary study. / Jayakody, Himali; Bonthius, Daniel J.; Longmuir, Reid; Joshi, Charuta.

In: Pediatric Neurology, Vol. 51, No. 5, 01.01.2014, p. 721-725.

Research output: Contribution to journalArticle

Jayakody, Himali ; Bonthius, Daniel J. ; Longmuir, Reid ; Joshi, Charuta. / Pediatric optic neuritis : Does a prolonged course of steroids reduce relapses? A preliminary study. In: Pediatric Neurology. 2014 ; Vol. 51, No. 5. pp. 721-725.
@article{dd271b41bec149419ba903ad11b7f4b8,
title = "Pediatric optic neuritis: Does a prolonged course of steroids reduce relapses? A preliminary study",
abstract = "Background Optic neuritis is an important pediatric disorder causing visual impairment. Because of the absence of pediatric-specific studies, data extrapolated from the adult-based optic neuritis treatment trial are used to guide management of pediatric patients. Recent literature promotes a prolonged course of oral steroids to prevent relapses. However, there are no published data to support this view.Patients who were recently treated in our hospital received a longer course of steroids, relative to those treated several years ago. We hypothesized that a longer course of steroids results in fewer relapses and better final visual acuity.Methods A retrospective analysis of 26 consecutive patients (age 4.5-19 years) treated for optic neuritis within the past 10 years was conducted.Patients received either a short course (2 weeks) or a prolonged course (more than 2 weeks) of steroids. Some patients were not treated. Mean follow-up was 70 weeks (3 weeks-10 years). Comparisons were made among the groups receiving 2 weeks of steroid treatment (16 of 26 patients) and greater than 2 weeks of steroid treatment (seven of 26 patients) to evaluate relapse rate, eventual visual acuity, and reported side effects.Results There were no significant differences in the relapse rates, reported side effects, and final visual acuity in the two treatment groups.Conclusions In this cohort, a prolonged course of steroids was not associated with reduced relapse rate, increased side effects, or improved visual outcome. This cohort was small, but the results do not identify any reason to deviate from the common approach of optic neuritis treatment, which is 2 weeks of steroids.",
keywords = "optic neuritis, pediatrics, steroid treatment, visual acuity, visual impairment, visual outcome",
author = "Himali Jayakody and Bonthius, {Daniel J.} and Reid Longmuir and Charuta Joshi",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.pediatrneurol.2014.07.020",
language = "English (US)",
volume = "51",
pages = "721--725",
journal = "Pediatric Neurology",
issn = "0887-8994",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Pediatric optic neuritis

T2 - Does a prolonged course of steroids reduce relapses? A preliminary study

AU - Jayakody, Himali

AU - Bonthius, Daniel J.

AU - Longmuir, Reid

AU - Joshi, Charuta

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Background Optic neuritis is an important pediatric disorder causing visual impairment. Because of the absence of pediatric-specific studies, data extrapolated from the adult-based optic neuritis treatment trial are used to guide management of pediatric patients. Recent literature promotes a prolonged course of oral steroids to prevent relapses. However, there are no published data to support this view.Patients who were recently treated in our hospital received a longer course of steroids, relative to those treated several years ago. We hypothesized that a longer course of steroids results in fewer relapses and better final visual acuity.Methods A retrospective analysis of 26 consecutive patients (age 4.5-19 years) treated for optic neuritis within the past 10 years was conducted.Patients received either a short course (2 weeks) or a prolonged course (more than 2 weeks) of steroids. Some patients were not treated. Mean follow-up was 70 weeks (3 weeks-10 years). Comparisons were made among the groups receiving 2 weeks of steroid treatment (16 of 26 patients) and greater than 2 weeks of steroid treatment (seven of 26 patients) to evaluate relapse rate, eventual visual acuity, and reported side effects.Results There were no significant differences in the relapse rates, reported side effects, and final visual acuity in the two treatment groups.Conclusions In this cohort, a prolonged course of steroids was not associated with reduced relapse rate, increased side effects, or improved visual outcome. This cohort was small, but the results do not identify any reason to deviate from the common approach of optic neuritis treatment, which is 2 weeks of steroids.

AB - Background Optic neuritis is an important pediatric disorder causing visual impairment. Because of the absence of pediatric-specific studies, data extrapolated from the adult-based optic neuritis treatment trial are used to guide management of pediatric patients. Recent literature promotes a prolonged course of oral steroids to prevent relapses. However, there are no published data to support this view.Patients who were recently treated in our hospital received a longer course of steroids, relative to those treated several years ago. We hypothesized that a longer course of steroids results in fewer relapses and better final visual acuity.Methods A retrospective analysis of 26 consecutive patients (age 4.5-19 years) treated for optic neuritis within the past 10 years was conducted.Patients received either a short course (2 weeks) or a prolonged course (more than 2 weeks) of steroids. Some patients were not treated. Mean follow-up was 70 weeks (3 weeks-10 years). Comparisons were made among the groups receiving 2 weeks of steroid treatment (16 of 26 patients) and greater than 2 weeks of steroid treatment (seven of 26 patients) to evaluate relapse rate, eventual visual acuity, and reported side effects.Results There were no significant differences in the relapse rates, reported side effects, and final visual acuity in the two treatment groups.Conclusions In this cohort, a prolonged course of steroids was not associated with reduced relapse rate, increased side effects, or improved visual outcome. This cohort was small, but the results do not identify any reason to deviate from the common approach of optic neuritis treatment, which is 2 weeks of steroids.

KW - optic neuritis

KW - pediatrics

KW - steroid treatment

KW - visual acuity

KW - visual impairment

KW - visual outcome

UR - http://www.scopus.com/inward/record.url?scp=84908271977&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908271977&partnerID=8YFLogxK

U2 - 10.1016/j.pediatrneurol.2014.07.020

DO - 10.1016/j.pediatrneurol.2014.07.020

M3 - Article

VL - 51

SP - 721

EP - 725

JO - Pediatric Neurology

JF - Pediatric Neurology

SN - 0887-8994

IS - 5

ER -